These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16442392)

  • 1. Heterogeneity of neointimal distribution of in-stent restenosis in patients with diabetes mellitus.
    Kaneda H; Ako J; Kataoka T; Takahashi T; Terashima M; Waseda K; Miyazawa A; Hassan A; Honda Y; Yock PG; Fitzgerald PJ
    Am J Cardiol; 2006 Feb; 97(3):340-2. PubMed ID: 16442392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of gender on neointimal hyperplasia following coronary artery stenting.
    Kaneda H; Ako J; Kataoka T; Takahashi T; Terashima M; Waseda K; Miyazawa A; Hassan AH; Honda Y; Yock PG; Fitzgerald PJ
    Am J Cardiol; 2007 Feb; 99(4):491-3. PubMed ID: 17293191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis.
    Sano K; Mintz GS; Carlier SG; Fujii K; Takebayashi H; Kimura M; Costa JR; Tanaka K; Costa RA; Lui J; Weisz G; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps EM; Collins M; Stone GW; Moses JW; Leon MB
    Am J Cardiol; 2006 Dec; 98(12):1559-62. PubMed ID: 17145209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
    Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB
    J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotic lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study.
    Takagi T; Yamamuro A; Tamita K; Katayama M; Morioka S
    J Cardiol; 2005 Apr; 45(4):139-47. PubMed ID: 15875535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neointimal progression and luminal narrowing in sirolimus-eluting stent treatment for bare metal in-stent restenosis: a quantitative intravascular ultrasound analysis.
    Sakurai R; Ako J; Hassan AH; Bonneau HN; Neumann FJ; Desmet W; Holmes DR; Yock PG; Fitzgerald PJ; Honda Y
    Am Heart J; 2007 Aug; 154(2):361-5. PubMed ID: 17643589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of bifurcation lesions treated with novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS PLUS trial.
    Miyazawa A; Ako J; Hassan A; Hasegawa T; Abizaid A; Verheye S; McClean D; Neumann FJ; Grube E; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):952-7. PubMed ID: 18044777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation.
    Takebayashi H; Mintz GS; Carlier SG; Kobayashi Y; Fujii K; Yasuda T; Costa RA; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps E; Collins MB; Colombo A; Stone GW; Leon MB; Moses JW
    Circulation; 2004 Nov; 110(22):3430-4. PubMed ID: 15557367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trial.
    Tsuchida K; García-García HM; Ong AT; Valgimigli M; Aoki J; Rademaker TA; Morel MA; van Es GA; Bruining N; Serruys PW
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):188-97. PubMed ID: 16400664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation.
    Suzuki Y; Ikeno F; Koizumi T; Tio F; Yeung AC; Yock PG; Fitzgerald PJ; Fearon WF
    JACC Cardiovasc Interv; 2008 Apr; 1(2):168-73. PubMed ID: 19463295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of reduced-dose sirolimus-eluting stents in the human coronary artery: serial IVUS analysis of neointimal hyperplasia and luminal dimension.
    Nakamura M; Abizaid A; Hirohata A; Honda Y; Sousa JE; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):946-51. PubMed ID: 17621671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.
    Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J
    Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study.
    Eshtehardi P; Cook S; Wandel S; Räber L; Wenaweser P; Togni M; Vogel R; Garachemani A; Eberli FR; Lüscher TF; Jüni P; Hess OM; Meier B; Windecker S
    EuroIntervention; 2010 Sep; 6(4):467-74. PubMed ID: 20884434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) study.
    Hur SH; Ako J; Shimada Y; Tsujino I; Hassan AH; Abizaid A; Shiran A; Lewis BS; Guagliumi G; Cohen SA; Honda Y; Fitzgerald PJ; Sousa JE
    J Invasive Cardiol; 2008 Aug; 20(8):411-6. PubMed ID: 18688066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents.
    Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Am J Cardiol; 2005 Jan; 95(1):107-9. PubMed ID: 15619404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation.
    Kaneda H; Koizumi T; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ
    Am J Cardiol; 2005 Nov; 96(9):1237-41. PubMed ID: 16253589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intravascular ultrasound study of Cypher, Taxus, and endeavor stents on relation between neointimal proliferation and residual plaque burden.
    Lee CH; Zhang J; Kailasam A; Tai BC; Ye F; Low AF; Hou X; Hay ET; Teo SG; Lim YT; Chen S; Tan HC
    J Interv Cardiol; 2008 Dec; 21(6):519-27. PubMed ID: 18973509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between neointimal regrowth and mechanism of acute lumen gain during the treatment of in-stent restenosis with or without supplementary intravascular radiation.
    Morino Y; Limpijankit T; Honda Y; Somrantin M; Waksman R; Bonneau HN; Yock PG; Mintz GS; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2003 Feb; 58(2):162-7. PubMed ID: 12552537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term changes in neointimal hyperplasia following implantation of bare metal stents assessed by integrated backscatter intravascular ultrasound.
    Tanaka S; Noda T; Iwama M; Tanihata S; Kawasaki M; Nishigaki K; Minagawa T; Watanabe S; Minatoguchi S
    Heart Vessels; 2013 Jul; 28(4):415-23. PubMed ID: 22828795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents.
    Mintz GS; Hong MK; Raizner AE; Lee CW; Kim JJ; Escolar E; Fearnot NE; Park SW; Park SJ; Weissman NJ
    Am J Cardiol; 2005 Jan; 95(1):105-7. PubMed ID: 15619403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.